BAC vs EDIT · P/E 13, rev $113.10B vs rev $32.3M
Bank of America Corp (BAC) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported BAC revenue for 2025-12-31 was $113.10B. Net income was $30.51B. Revenue was up 11.0% from 2024-12-31 to 2025-12-31. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
BAC currently screens at market cap $382.01B and trailing P/E 13.4. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the BAC and EDIT stock pages for the full models.
Not investment advice.